Skip to main content
    R

    Reviva Pharmaceuticals Holdings Inc. (RVPH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.35
    -0.04 (-9.13%)

    Market Cap: $4.63M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Reviva Pharmaceuticals Holdings Inc. (RVPH) Competitors

    Updated Nov 13, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Reviva Pharmaceuticals Holdings are Theriva Biologics (TOVX), Kiora Pharmaceuticals (KPRX) and Processa Pharmaceuticals (PCSA). By market cap, Reviva Pharmaceuticals Holdings ranks 7th of the 13 companies on this page; VistaGen Therapeutics (VTGN) is the largest at $8.01M.

    Peer Comparison

    RVPH's ROIC of -90.2% is above the peer median of -156.2%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Reviva Pharmaceuticals Holdings (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    Processa Pharmaceuticals Inc (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)$5.39MN/AN/A0.0%N/A0.0%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    VistaGen Therapeutics Inc (VTGN)$8.01MN/A3.4x0.0%N/A-46.5%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Aprea Therapeutics Inc (APRE)$5.91MN/AN/A0.0%N/A-98.4%0.00%
    Peer median$4.71MN/A13.9x0.0%-156.2%0.0%0.00%
    Market data as of Nov 13, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Reviva Pharmaceuticals Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    Processa Pharmaceuticals Inc (PCSA)
    Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients...
    PCSA competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)
    Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated...
    CVKD competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    VistaGen Therapeutics Inc (VTGN)
    VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential...
    VTGN competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Aprea Therapeutics Inc (APRE)
    Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor...
    APRE competitors

    Frequently Asked Questions About RVPH

    Who are Reviva Pharmaceuticals Holdings' main competitors?

    The companies most similar to Reviva Pharmaceuticals Holdings include Theriva Biologics (TOVX), Kiora Pharmaceuticals (KPRX), Processa Pharmaceuticals (PCSA), Neurosense Therapeutics (NRSN) and Revelation Biosciences (REVB), listed from the closest match.

    Who is Reviva Pharmaceuticals Holdings' biggest competitor?

    VistaGen Therapeutics (VTGN) is the largest of the similar companies at $8.01M; Theriva Biologics (TOVX) is the closest match by business profile, size, sector and industry.

    How does RVPH stock compare with its competitors?

    RVPH's net margin is 0.0% against a peer median of 0.0%.

    Which of Reviva Pharmaceuticals Holdings' competitors pays a higher dividend?

    Reviva Pharmaceuticals Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Reviva Pharmaceuticals Holdings bigger than its competitors?

    No. Reviva Pharmaceuticals Holdings is 7th by market cap among the 13 companies on this page; the largest is VistaGen Therapeutics (VTGN) at $8.01M.